Erik Nerpin
Chairman
Born year: 1961
Member of the board since: 2022
Background: Bachelor of Laws from Uppsala University and Master of Laws at Boston University. Lawyer and founder of Advokatfirman Nerpin AB. Specialized in business administration, corporate governance and stock exchange issues.
Ongoing assignments: Chairman of Diamyd Medical Aktiebolag, Kancera AB, Blasieholmen Investment Group Equity AB (publ), Blasieholmen Investment Group Seed AB (publ), Wicket Gaming AB and Hilbert Group AB (publ). Board member of EffNet AB, Blasieholmen Investment Group AB, Naihsadrak AB, Advokatfirman Nerpin AB, Kancera Förvaltning AB, Ittot AB, Sallisac AB, Effnetplattformen Holding AB and Identity Devices Sweden Holding AB.
Previous assignments (last 5 years): Chairman of PILA PHARMA AB. Board member of FFT Consumer AB, Karessa Pharma AB, Freemelet Holding AB (publ), Effnetplattformen AB, Nenarg AB, Hudya AB, Axolot Solutions Holding AB, Divio Holding AB, Nicoccino Holding AB (publ), GoldBlue AB (publ), NORD Nordic Retail & Distribution Holding AB, Hitech & Development Wireless Sweden Holding AB, Axxonen Holding AB, CasinoWilds Holding AB, Effnetplattformen AB, ISR Immune System Regulation Holding AB, Klaria AB and Aligera AB
Holding in Neovici: 275 000 B shares.
Independent in relation to the company and main owners: Yes
